Publicaciones en colaboración con investigadores/as de Universidad Europea de Madrid (35)

2024

  1. A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24

    BJU International, Vol. 134, Núm. 4, pp. 568-577

  2. Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

    Pediatric Blood and Cancer, Vol. 71, Núm. 8

  3. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  4. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial

    European urology oncology, Vol. 7, Núm. 3, pp. 462-468

  5. Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy

    Cancers, Vol. 16, Núm. 16

  6. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  7. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  3. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer

    World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838

  4. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

  5. Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 461-466

2022

  1. Aspiration of excess follicles before intrauterine insemination in high response cycles

    Reproductive Medicine and Biology, Vol. 21, Núm. 1

  2. Bone health and therapeutic agents in advanced prostate cancer

    Frontiers in Bioscience - Landmark, Vol. 27, Núm. 1

  3. Development of castration resistance in prostate cancer patients treated with luteinizing hormone-releasing hormone analogues (LHRHa): results of the ANARESISTANCE study

    World Journal of Urology, Vol. 40, Núm. 10, pp. 2459-2466

  4. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial

    Radiotherapy and Oncology, Vol. 172, pp. 1-9

  5. Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus

    Radiotherapy and Oncology, Vol. 176, pp. 199-207

  6. VA-ECMO support in patients with refractory cardiogenic shock. A 6-year multicenter registry

    REC: CardioClinics, Vol. 57, Núm. 1, pp. 7-13

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

  2. Adjuvant versus early salvage radiotherapy for prostate cancer patients: Time to move on

    Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 6, pp. 351-356